Gil M. Labrucherie, SVP, COO & CFO at NEKTAR THERAPEUTICS (NKTR), sold 13,454 shares at $22.51 ($303K) on 2020-05-18, disclosed to the SEC on 2020-05-20.
Seasonal sale ($303k) by SVP, COO & CFO — this insider has traded NKTR in May in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.51 | 5,727 | $129K | 42.5% |
| 2 | $22.51 | 5,727 | $129K | 42.5% |
| 3 | $22.62 | 2,000 | $45K | 14.9% |
| Total | $22.53 avg | 13,454 | $303K | 100% |
| Filing → |
| NKTR | SELL | 2022-05-17 | $138K | — | Filing → |
| RZLT | BUY | 2022-05-09 | $400K | — | Filing → |
| NKTR | SELL | 2022-02-18 | $166K | — | Filing → |